Review of Parkinson’s Disease Treatment and Future Therapies
Eric Manning
|
Abstract
Parkinson’s Disease (PD) is a progressive neurodegenerative disorder that can affect an individual’s ability to perform daily activities. The disease belongs to a group of motor system disorders and is characterized by the result of a loss of dopamine-producing brain cells. There are no definitive causes of this condition, but there are many factors currently being studied. Genetics, environmental factors, or a combination of both may be potential causes of the disease. This article will review current treatment regimens used in practice, previous studies done on novel therapies, and future therapies that could have clinical significance.
The review will go through each medication class and highlight their mechanisms, potential side effects, and use in the treatment of Parkinson’s disease. Clinical trials researching newly approved medications are referenced in the article. Areas of future drug development that are being studied are also reviewed. New information is constantly being discovered regarding the pathophysiology of Parkinson’s Disease, which in turn leads researchers to look into new potential therapies.
The review will go through each medication class and highlight their mechanisms, potential side effects, and use in the treatment of Parkinson’s disease. Clinical trials researching newly approved medications are referenced in the article. Areas of future drug development that are being studied are also reviewed. New information is constantly being discovered regarding the pathophysiology of Parkinson’s Disease, which in turn leads researchers to look into new potential therapies.
Full Text
Vol1Article8.pdf | |
File Size: | 367 kb |
File Type: |